Tyra Biosciences (TYRA) News Today $9.50 -0.09 (-0.94%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$9.51 +0.01 (+0.11%) As of 06/18/2025 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TYRA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Tyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells $70,729.32 in StockJune 17 at 5:04 AM | insidertrades.comTyra Biosciences, Inc. (NASDAQ:TYRA) Director Gilla Kaplan Sells 6,814 SharesTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Gilla Kaplan sold 6,814 shares of the firm's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $10.38, for a total value of $70,729.32. Following the completion of the transaction, the director now owns 37,809 shares of the company's stock, valued at approximately $392,457.42. The trade was a 15.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.June 16 at 8:50 PM | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells $154,650.00 in StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Gilla Kaplan sold 15,000 shares of Tyra Biosciences stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $10.31, for a total value of $154,650.00. Following the sale, the director now directly owns 44,623 shares in the company, valued at approximately $460,063.13. The trade was a 25.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.June 16 at 8:50 PM | marketbeat.comGilla Kaplan Sells 30,000 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Gilla Kaplan sold 30,000 shares of the firm's stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $10.31, for a total transaction of $309,300.00. Following the sale, the director now owns 59,623 shares of the company's stock, valued at $614,713.13. This trade represents a 33.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.June 16 at 8:50 PM | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Down 3% - What's Next?Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 3% - Here's What HappenedJune 16 at 2:38 PM | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Up 7.1% - Time to Buy?Tyra Biosciences (NASDAQ:TYRA) Trading 7.1% Higher - Here's What HappenedJune 10, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Gap Up - Time to Buy?Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up - Still a Buy?June 9, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of "Buy" from AnalystsShares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have been assigned a consensus rating of "Buy" from the six ratings firms that are currently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12 monthJune 6, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Trading Down 6% - Here's What HappenedTyra Biosciences (NASDAQ:TYRA) Trading Down 6% - Should You Sell?June 5, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Sees Significant Growth in Short InterestTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) saw a significant increase in short interest in May. As of May 15th, there was short interest totalling 5,100,000 shares, an increase of 17.2% from the April 30th total of 4,350,000 shares. Approximately 16.0% of the shares of the stock are short sold. Based on an average daily volume of 319,800 shares, the days-to-cover ratio is presently 15.9 days.June 4, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Stake Trimmed by Canaan Partners XI LLCCanaan Partners XI LLC reduced its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 0.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,144,590 shares of the company's stock afJune 3, 2025 | marketbeat.comMillennium Management LLC Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)Millennium Management LLC increased its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 2,900.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 315,141 shares of the company's stock after buying anMay 31, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Trading 6.1% Higher - Here's WhyTyra Biosciences (NASDAQ:TYRA) Shares Up 6.1% - Still a Buy?May 30, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Now Covered by Piper SandlerPiper Sandler began coverage on shares of Tyra Biosciences in a report on Wednesday. They set an "overweight" rating and a $33.00 price objective on the stock.May 23, 2025 | marketbeat.comHC Wainwright Has Optimistic Outlook of TYRA FY2025 EarningsTyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Analysts at HC Wainwright raised their FY2025 earnings per share (EPS) estimates for shares of Tyra Biosciences in a research report issued on Monday, May 19th. HC Wainwright analyst M. Kapoor now forecasts that the company will earn ($2.27) peMay 23, 2025 | marketbeat.comEquities Analysts Offer Predictions for TYRA FY2026 EarningsTyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Equities researchers at HC Wainwright issued their FY2026 earnings per share (EPS) estimates for Tyra Biosciences in a research report issued to clients and investors on Monday, May 19th. HC Wainwright analyst M. Kapoor anticipates that the comMay 22, 2025 | marketbeat.comVestal Point Capital LP Makes New Investment in Tyra Biosciences, Inc. (NASDAQ:TYRA)Vestal Point Capital LP bought a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 990,000 shares of the company's stock, valued at approximately $13,761,000. VestMay 21, 2025 | marketbeat.comDimensional Fund Advisors LP Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)Dimensional Fund Advisors LP boosted its stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 283.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 37,981 shares of the company's stock after acquiring an additional 28,074 shares durinMay 19, 2025 | marketbeat.comJanus Henderson Group PLC Has $24.29 Million Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)Janus Henderson Group PLC increased its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 63.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,746,320 shares oMay 18, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Purchases Shares of 244,245 Tyra Biosciences, Inc. (NASDAQ:TYRA)Jacobs Levy Equity Management Inc. purchased a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 244,245 shares of the compMay 17, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Shares Acquired by Orbimed Advisors LLCOrbimed Advisors LLC increased its position in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 91.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,470,086 shares of the company's stock after buying an additional 701,4May 15, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes $1.53 Million Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)Cubist Systematic Strategies LLC bought a new stake in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 109,748 shares of the company's stock, valuMay 15, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Rating of "Buy" by BrokeragesTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) has been given a consensus recommendation of "Buy" by the six brokerages that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price target amMay 13, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPSTyra Biosciences (NASDAQ:TYRA - Get Free Report) posted its earnings results on Thursday. The company reported ($0.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.49) by $0.02.May 12, 2025 | marketbeat.comTyra Biosciences to Participate at Upcoming Investor ConferencesMay 12, 2025 | prnewswire.comFarallon Capital Management LLC Invests $13.91 Million in Tyra Biosciences, Inc. (NASDAQ:TYRA)Farallon Capital Management LLC bought a new stake in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,000,981 shares of the compMay 11, 2025 | marketbeat.comOne Tyra Biosciences Insider Raised Stake By 284% In Previous YearMay 9, 2025 | finance.yahoo.com54,783 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Acquired by Raymond James Financial Inc.Raymond James Financial Inc. purchased a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 54,783 shares of the company's stock, valued at approximately $761,000. Raymond James FiMay 9, 2025 | marketbeat.comTyra Biosciences Reports First Quarter 2025 Financial Results and HighlightsMay 8, 2025 | prnewswire.comTyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by BVF Inc. ILBVF Inc. IL trimmed its holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 15.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,944,194 shares of the company's stock afteMay 6, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Invests $543,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA)Susquehanna Fundamental Investments LLC acquired a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 39,093 shares of the company's stock, valued at approximatMay 6, 2025 | marketbeat.com29,100 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Renaissance Technologies LLCRenaissance Technologies LLC acquired a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 29,100 shares of the company's stock,May 6, 2025 | marketbeat.comAlly Bridge Group NY LLC Cuts Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA)Ally Bridge Group NY LLC cut its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 35.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 175,063 shares of the company's stock after selling 95,012 shares dMay 4, 2025 | marketbeat.comBoxer Capital Management LLC Buys Shares of 2,027,678 Tyra Biosciences, Inc. (NASDAQ:TYRA)Boxer Capital Management LLC purchased a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,027,678 shares of the company's stock, vMay 4, 2025 | marketbeat.comMarshall Wace LLP Acquires 34,463 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)Marshall Wace LLP grew its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 175.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,077 shares of the company's stock after purchasinMay 4, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by RA Capital Management L.P.RA Capital Management L.P. raised its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,637,290 shares of the company's stoMay 3, 2025 | marketbeat.comTyra Biosciences (TYRA) to Release Earnings on ThursdayTyra Biosciences (NASDAQ:TYRA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-tyra-biosciences-inc-stock/)May 3, 2025 | marketbeat.comNantahala Capital Management LLC Buys New Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA)Nantahala Capital Management LLC bought a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 100,000 shares of the company's stock, valued at approximately $1,3April 30, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by JPMorgan Chase & Co.JPMorgan Chase & Co. lowered its holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 75.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,115 shares of the company's stock after selliApril 28, 2025 | marketbeat.comWalleye Capital LLC Sells 63,617 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)Walleye Capital LLC decreased its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 50.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 62,980 shares of the company's stock after selling 63,617 shares during the period. WalleApril 24, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of "Buy" by BrokeragesShares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have been assigned an average rating of "Buy" from the six analysts that are presently covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price targetApril 19, 2025 | marketbeat.comVanguard Group Inc. Sells 37,643 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)Vanguard Group Inc. reduced its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 3.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,207,765 shares of the company's stock after selling 37,643 shaApril 19, 2025 | marketbeat.comInvestment Counsel Co. of Nevada Purchases New Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA)Investment Counsel Co. of Nevada acquired a new position in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 85,020 shares of the company's sApril 16, 2025 | marketbeat.comRaymond James Financial Inc. Invests $761,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA)Raymond James Financial Inc. purchased a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 54,783 shares of the company's stock, valued at approxApril 7, 2025 | marketbeat.comHC Wainwright Expects Lower Earnings for Tyra BiosciencesTyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Investment analysts at HC Wainwright dropped their Q1 2025 EPS estimates for shares of Tyra Biosciences in a report released on Monday, March 31st. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings of ($0.56) perApril 5, 2025 | marketbeat.comPictet Asset Management Holding SA Takes $4.92 Million Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)Pictet Asset Management Holding SA bought a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 354,012 shares of the company's stock, valued at approximApril 5, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $30.00 target price on shares of Tyra Biosciences in a research report on Monday.April 1, 2025 | marketbeat.comWhat is Wedbush's Estimate for TYRA FY2029 Earnings?Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Stock analysts at Wedbush issued their FY2029 earnings per share estimates for shares of Tyra Biosciences in a research note issued to investors on Friday, March 28th. Wedbush analyst R. Driscoll expects that the company will post earnings perMarch 31, 2025 | marketbeat.comTyra Biosciences price target lowered to $28 from $29 at BofAMarch 30, 2025 | markets.businessinsider.comTyra Biosciences' (TYRA) "Outperform" Rating Reiterated at WedbushWedbush restated an "outperform" rating and issued a $30.00 target price on shares of Tyra Biosciences in a research note on Friday.March 29, 2025 | marketbeat.com Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address TYRA Media Mentions By Week TYRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TYRA News Sentiment▼0.250.69▲Average Medical News Sentiment TYRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TYRA Articles This Week▼84▲TYRA Articles Average Week Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DNLI News CGON News HRMY News TWST News BLTE News AGIO News IDYA News SDGR News INDV News GLPG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TYRA) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TYRA Stock Free TYRA Stock Alerts